What happened

Ashish Arora, chief executive of Cricut, Inc. (NASDAQ: CRCT), sold 210,000 Class A common shares for about $1.76 million. The sales pared Arora's direct stake, but the chief executive retained most of the shares held before the trades.

Arora is also a director, and the filing identifies Arora as a 10% owner. That ownership designation is separate from the direct Class A share count used to measure how much of the position Arora sold.

Arora sold the same number of shares each day, but the average price varied. The sales covered 70,000 shares a day at weighted average prices of $8.57 on Nov. 18, $8.28 on Nov. 19 and $8.34 on Nov. 20.

Those averages cover multiple trades at different prices. Individual sales ranged from $8.30 to $8.70 on the opening day and from $8.12 to $8.56 on the second day. On the final day, prices ranged from $8.23 to $8.47.

Why it matters

OptimistFi calculates that the sales accounted for 4.5% of the 4,662,135 shares Arora held before the first sale. The direct holding fell to 4,592,135 shares after the first day and 4,522,135 after the second. Arora finished the selling period with 4,452,135 shares.

The proceeds went to Arora as the selling shareholder, not to Cricut. Each day's reported balance reflects a sale of common stock Arora already owned directly.

The trades followed a Rule 10b5-1 trading plan Arora adopted on Aug. 11. The plan was in place before the selling began, making the transactions a clearer measure of the change in ownership than of Arora's view of the business.

OptimistFi has argued that keeping existing Cricut users engaged helps the company earn recurring, high-margin revenue from subscriptions and consumables. The reduction in Arora's direct holding leaves that view unchanged.

Explain the financial terms

A Rule 10b5-1 plan is a trading plan an insider sets up in advance, while not holding inside information, that schedules later trades.

What's next

Cricut's next quarterly report is the next test for that view, which would gain support from year-over-year growth in subscription and consumables revenue.

Sources checked automatically Nov 21, 2026 · Human review: none
Thesis impactCRCT: no published thesis yet.